SEC 13F Intelligence

Partners Capital Investment Group, LLP / ALXN

Partners Capital Investment Group, LLP’s Alexion Pharmaceuticals Inc Position

Does Partners Capital Investment Group, LLP own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 170.0K shares worth $27M in Q4 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$27M
Q4 2020
Shares
170.0K
% of Portfolio
+1.51%
Quarters Held
9
position exited

Position History ALXN

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $6MQ2 ’19: $7MQ2 ’19Q3 ’19: $7MQ4 ’19: $8MQ4 ’19Q1 ’20: $9MQ2 ’20: $16MQ2 ’20Q3 ’20: $19MQ4 ’20: $27MQ4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2020170.0K$27M+1.51%
Q3 2020165.5K$19M+1.17%
Q2 2020140.0K$16M+0.77%
Q1 2020103.7K$9M+0.64%
Q4 201973.4K$8M+0.60%
Q3 201971.6K$7M+0.61%
Q2 201951.9K$7M+0.68%
Q1 201947.4K$6M+0.63%
Q4 201842.0K$4M+0.58%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Partners Capital Investment Group, LLP’s full portfolio or all institutional holders of ALXN.